Abcam

Anti-Progesterone Receptor antibody [SP42] - BSA and Azide free (ab236222)

#AB236222 · $8,160

Supplier page Find this product

Citation evidence for this product is being indexed.

We're building a comprehensive citation database. Check back soon.

Similar products

ProductVendorEvidencePricePapers
Progesterone ReceptorMouseAgilent/Dako63—100
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63—27
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63—22
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63—1
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63—1
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63——
Progesterone Receptor (PR)rabbitSpring Bioscience63——
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63——
Biotin-conjugated Progesterone Receptor Monoclonal antibodyMouseProteintech———
Anti-Progesterone Receptor Kit Antibody, UnconjugatedLeica Biosystems63——
Anti-Progesterone Receptor Monoclonal Antibody, UnconjugatedLeica Biosystems63——
Anti-Progesterone Receptor antibody [PR500] (ab187295)MouseAbcam———
Progesterone Receptor (PR)rabbitSpring Bioscience63——
Anti-Progesterone Receptor antibody [YR85] (ab32085)RabbitAbcam—$265—
Anti-Progesterone Receptor antibody [PR500] - BSA and Azide free (ab269795)MouseAbcam———
FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636, Ready-to-Use (Link), UnconjugatedMouseAgilent/Dako———
Anti-Progesterone Receptor antibody [PR501] (ab187296)MouseAbcam———
Anti-Progesterone Receptor antibody [PR501] - BSA and Azide free (ab269796)MouseAbcam—$905—
Monoclonal Mouse Anti-Human Progesterone Receptor (Dako Omnis) Clone PgR 1294MouseAgilent/Dako———
Anti-Progesterone Receptor (PgR) Ab-6 Monoclonal Antibody, UnconjugatedmouseLab Vision———

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.